4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Ligand Pharmaceuticals Incorporated (LGND) operates in the Biotechnology industry and is headquartered in Jupiter, United States with about 47 employees. Its market capitalization is roughly $6 billion. In the fiscal year ended 2025-12-31, LGND reported $268M in revenue and $124M in net income.
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.
Interactive charts & full statements → Open the LGND valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $268M | $167M | $131M | $196M | — |
| Gross Profit | $254M | $156M | $121M | $143M | — |
| Operating Income (EBIT) | $47M | $23M | $10M | $3M | — |
| Net Income | $124M | ($4M) | $52M | ($33M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $52M | $60M | $116M | $48M | $45M | — |
| Gross Profit | $48M | $57M | $112M | $45M | $40M | — |
| Operating Income (EBIT) | $17M | $20M | $54M | $10M | ($37M) | — |
| Net Income | ($13M) | $45M | $117M | $5M | ($42M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $1.6B | $942M | $787M | $763M | — |
| Total Liabilities | $543M | $111M | $86M | $165M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive LGND viewer.
About TickerBase · Data methodology & sources